Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-04-10, Stock:JNJ, The news for the past five days is as follows:
2019-04-03: NEWS1: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.NEWS2: Roche Extends Offer Period for Spark Therapeutics Acquisition.NEWS3: Roche Extends Offer Period for Spark Therapeutics Acquisition.NEWS4: Health Care Sector Update for 04/03/2019: EVGN, ADXS, ACHN, JNJ, PFE, ABT, MRK, AMGN.NEWS5: Health Care Sector Update for 04/03/2019: EVGN, ADXS, ACHN, JNJ, PFE, ABT, MRK, AMGN.NEWS6: Roche Extends Offer Period for Spark Therapeutics Acquisition.NEWS7: Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for April 04, 2019.NEWS8: Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for April 04, 2019.NEWS9: Micron Technology, Tencent and two dozen other companies most likely to benefit from a China trade deal.
2019-04-04: NEWS1: Oklahoma drops some claims against opioid manufacturers.NEWS2: Oklahoma drops several claims in opioid case against J&J, Teva.NEWS3: Editas (EDIT) Inks Cross Licensing Agreement with BlueRock.NEWS4: Editas (EDIT) Inks Cross Licensing Agreement with BlueRock.NEWS5: Oklahoma drops some claims against opioid manufacturers.NEWS6: Editas (EDIT) Inks Cross Licensing Agreement with BlueRock.NEWS7: Dow Movers: WBA, DOW.NEWS8: Dow Movers: WBA, DOW.NEWS9: IVV, JNJ, JPM, PG: Large Inflows Detected at ETF.NEWS10: IVV, JNJ, JPM, PG: Large Inflows Detected at ETF.NEWS11: STATELINE-Opioid Crisis ‘Kingpin’ Is Oklahoma’s New Target in Lawsuit.NEWS12: Health Care Sector Update for 04/04/2019: NSPR, REPH, RWLK, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Health Care Sector Update for 04/04/2019: NSPR, REPH, RWLK, JNJ, PFE, ABT, MRK, AMGN.NEWS14: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.NEWS15: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.
2019-04-05: NEWS1: Boeing Stock Already Is on Its Way Back After the 737 MAX Debacle.NEWS2: Boeing Stock Already Is on Its Way Back After the 737 MAX Debacle.NEWS3: Why Tandem Diabetes Stock Will Rally Much Further.NEWS4: What's Been Going On With Emerald Bioscience?.NEWS5: Boeing Stock Already Is on Its Way Back After the 737 MAX Debacle.NEWS6: Health Care Sector Update for 04/05/2019: SYRS, AQB, MACK, JNJ, PFE, ABT, MRK, AMGN.NEWS7: Health Care Sector Update for 04/05/2019: SYRS, AQB, MACK, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Stocks making the biggest moves premarket: Tesla, Viacom, Intel, J&J, Amazon & more.NEWS9: Stocks making the biggest moves premarket: Tesla, Viacom, Intel, J&J, Amazon & more.
2019-04-08: NEWS1: What's Been Going On With Emerald Bioscience?.NEWS2: Company News For Apr 8, 2019.NEWS3: Company News For Apr 8, 2019.NEWS4: J&J Stock on an Uptrend This Year So Far: More Room to Run?.NEWS5: J&J Stock on an Uptrend This Year So Far: More Room to Run?.NEWS6: Aeglea (AGLE) Reports New Positive Data for Pegzilarginase.NEWS7: Aeglea (AGLE) Reports New Positive Data for Pegzilarginase.NEWS8: Here's Why Axsome Therapeutics Rocketed 78.8% Higher in March.NEWS9: Here's Why Axsome Therapeutics Rocketed 78.8% Higher in March.NEWS10: Aeglea (AGLE) Reports New Positive Data for Pegzilarginase.NEWS11: J&J Stock on an Uptrend This Year So Far: More Room to Run?.NEWS12: Company News For Apr 8, 2019.NEWS13: Johnson & Johnson (NYSE:JNJ) Insiders Have Been Selling.NEWS14: Here&apos;s Why Axsome Therapeutics Rocketed 78.8% Higher in March.NEWS15: Better Buy: AbbVie vs. Johnson & Johnson.NEWS16: Better Buy: AbbVie vs. Johnson & Johnson.
2019-04-09: NEWS1: These 10 VC-backed companies scored the biggest Bay Area exits in Q1.NEWS2: Johnson & Johnson (JNJ) Stock Moves -0.47%: What You Should Know.NEWS3: Children's National taps Johnson & Johnson for incubator at Walter Reed.NEWS4: Geron's Blood Cancer Candidate Creates Buying Opportunity, Needham Says In Upgrade.NEWS5: 10 Dow Jones Stocks Holding the Blue Chip Index Back.NEWS6: Earnings Preview: Johnson & Johnson (JNJ) Q1 Earnings Expected to Decline.NEWS7: Earnings Preview: Johnson & Johnson (JNJ) Q1 Earnings Expected to Decline.NEWS8: Earnings Preview: Johnson & Johnson (JNJ) Q1 Earnings Expected to Decline.NEWS9: Glaxo's Dovato Gets FDA Nod for Treatment-Naive HIV Patients.NEWS10: Glaxo's Dovato Gets FDA Nod for Treatment-Naive HIV Patients.NEWS11: Health Care Sector Update for 04/09/2019: VXRT, ZGNX, NVS, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Health Care Sector Update for 04/09/2019: VXRT, ZGNX, NVS, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Special Report: As Baby Powder concerns mounted, J&J focused marketing on minority, overweight women.NEWS14: Glaxo's Dovato Gets FDA Nod for Treatment-Naive HIV Patients.NEWS15: Alcon tops $28 bln market cap in decade's biggest Swiss stock deal.

Answer: Rise